Showing results (951-960 of 1,009) with videos related to

Sort By:
Pageof 101
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
RMD Open|August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task forcePavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
Nature Communications|April 26, 2020
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritisNarges Tajik, Michael Frech, Oscar Schulz, et al.
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
Pageof 101